P3 Health Partners Inc Revenue Growth Rates (PIII), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
P3 Health Partners Inc   (NASDAQ: PIII)
 

PIII's Revenue Growth by Quarter and Year

P3 Health Partners Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PIII Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 386.38
1st Quarter March 386.39
FY 772.77





PIII Revenue second quarter 2026 Y/Y Growth Comment
P3 Health Partners Inc reported Revenue growth of 8.6% year on year in the second quarter 2026, to $ 386.38 millions, this is lower than P3 Health Partners Inc 's recent average Revenue increase of 11.94%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 137 other companies have achieved higher Revenue growth. While P3 Health Partners Inc ' s Revenue increase of 8.6% ranks overall at the positon no. 2607 in the second quarter 2026.


PIII Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 3.81 % 6.87 % 34.33 %
3rd Quarter September - -4.66 % 25.58 % 16.15 %
2nd Quarter June 8.6 % -6.16 % 15.21 % 22.13 %
1st Quarter March 3.53 % -3.93 % 28.61 % 10.43 %
FY   - -2.76 % 18.48 % -

Financial Statements
P3 Health Partners Inc 's second quarter 2026 Revenue $ 386.38 millions PIII's Income Statement
P3 Health Partners Inc 's second quarter 2025 Revenue $ 355.79 millions Quarterly PIII's Income Statement


PIII Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 11.46 % 2.37 % 20.29 %
3rd Quarter September - -2.96 % -4.49 % -12.38 %
2nd Quarter June -0 % -4.67 % -2.4 % 8.94 %
1st Quarter March 0.41 % 0.69 % 12 % 16.99 %
FY (Year on Year)   - -2.76 % 18.48 % -


Back to PIII Growth rate Comparisons >> Back to PIII Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #372
Overall #2607

Revenue Y/Y Growth Statistics
High Average Low
40.99 % 11.94 % -8.16 %
(Mar 31 2023)   (Sep 30 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #372
Overall #2607
Revenue Y/Y Growth Statistics
High Average Low
40.99 % 11.94 % -8.16 %
(Mar 31 2023)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

P3 Health Partners Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5456261022.22 % 259821946.61 % -100 %
(Dec 31 2021)  


PIII's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 P3 Health Partners Inc disclosed no change in Revenue from the first quarter by -0% to $ 386.38 millions, from $ 386.39 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 72 other companies have achieved higher Revenue quarter on quarter growth. While P3 Health Partners Inc 's Revenue growth quarter on quarter, overall rank is 1764.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #235
Overall #1764
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #235
Overall #1764
Revenue Q/Q Growth Statistics
High Average Low
5456261022.22 % 259821946.61 % -100 %
(Dec 31 2021)  


PIII's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 P3 Health Partners Inc disclosed no change in Revenue from the first quarter by -0% to $ 386.38 millions, from $ 386.39 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 72 other companies have achieved higher Revenue quarter on quarter growth. While P3 Health Partners Inc 's Revenue growth quarter on quarter, overall rank is 1764.


P3 Health Partners Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,502.84 $ 1,472.25 $ 1,459.08 $ 1,444.95 $ 1,461.82
Y / Y Revenue Growth (TTM) 2.81 % -0.87 % -2.76 % -2.15 % 4.2 %
Year on Year Revenue Growth Overall Ranking # 2031 # 1273 # 661 # 488 # 411
Seqeuential Revenue Change (TTM) 2.08 % 0.9 % 0.98 % -1.15 % -1.57 %
Seq. Revenue Growth (TTM) Overall Ranking # 2607 # 2323 # 2020 # 1638 # 1687


Cumulative Revenue growth Comment
Although P3 Health Partners Inc 's Annual Revenue growth year on year were below company's average 11.94% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.81% year on year, from -0.87% in Mar 31 2026.

In the Healthcare sector 303 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1273 to 2031.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 304
Overall # 2031

Revenue TTM Y/Y Growth Statistics
High Average Low
40.99 %
 11.94 %
-8.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 372
S&P 500 # 2607
Cumulative Revenue growth Comment
Although P3 Health Partners Inc 's Annual Revenue growth year on year were below company's average 11.94% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.81% year on year, from -0.87% in Mar 31 2026.

In the Healthcare sector 303 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1273 to 2031.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 304
Overall # 2031

Revenue TTM Y/Y Growth Statistics
High Average Low
40.99 %
11.94 %
-8.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 372
S&P 500 # 2607




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PIII's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Penumbra Inc14.90%$ 14.904 millions
Rockwell Medical inc 14.69%$ 14.687 millions
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions


About P3 Health Partners Inc Revenue Growth Rates (PIII), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: P3 Health Partners Inc (CIK 1832511).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001832511-26-000034
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: P3 Health Partners Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.